These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 30810932)
21. Benzothiazole Derivative as a Novel Mycobacterium tuberculosis Shikimate Kinase Inhibitor: Identification and Elucidation of Its Allosteric Mode of Inhibition. Mehra R; Rajput VS; Gupta M; Chib R; Kumar A; Wazir P; Khan IA; Nargotra A J Chem Inf Model; 2016 May; 56(5):930-40. PubMed ID: 27149193 [TBL] [Abstract][Full Text] [Related]
22. Structure-based discovery of novel inhibitors of Mycobacterium tuberculosis CYP121 from Indonesian natural products. Prasasty VD; Cindana S; Ivan FX; Zahroh H; Sinaga E Comput Biol Chem; 2020 Apr; 85():107205. PubMed ID: 31981965 [TBL] [Abstract][Full Text] [Related]
23. Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Saxena S; Abdullah M; Sriram D; Guruprasad L J Biomol Struct Dyn; 2018 Sep; 36(12):3184-3198. PubMed ID: 28948866 [TBL] [Abstract][Full Text] [Related]
24. Identification of Potential Antituberculosis Drugs Through Docking and Virtual Screening. Anand R Interdiscip Sci; 2018 Jun; 10(2):419-429. PubMed ID: 27147082 [TBL] [Abstract][Full Text] [Related]
25. Identification of anti-filarial leads against aspartate semialdehyde dehydrogenase of Wolbachia endosymbiont of Brugia malayi: combined molecular docking and molecular dynamics approaches. Amala M; Rajamanikandan S; Prabhu D; Surekha K; Jeyakanthan J J Biomol Struct Dyn; 2019 Feb; 37(2):394-410. PubMed ID: 29334340 [TBL] [Abstract][Full Text] [Related]
26. Molecular modeling and simulation of FabG, an enzyme involved in the fatty acid pathway of Streptococcus pyogenes. Shafreen RB; Pandian SK J Mol Graph Model; 2013 Sep; 45():1-12. PubMed ID: 23988477 [TBL] [Abstract][Full Text] [Related]
27. Molecular docking, molecular dynamics simulations and binding free energy studies of interactions between Mycobacterium tuberculosis Pks13, PknG and bioactive constituents of extremophilic bacteria. Nyambo K; Tapfuma KI; Adu-Amankwaah F; Julius L; Baatjies L; Niang IS; Smith L; Govender KK; Ngxande M; Watson DJ; Wiesner L; Mavumengwana V Sci Rep; 2024 Mar; 14(1):6794. PubMed ID: 38514663 [TBL] [Abstract][Full Text] [Related]
28. Virtual Screening of Novel Glucosamine-6-Phosphate Synthase Inhibitors. Lather A; Sharma S; Khatkar A Comb Chem High Throughput Screen; 2018; 21(3):182-193. PubMed ID: 29600755 [TBL] [Abstract][Full Text] [Related]
29. Identification of glucosyl-3-phosphoglycerate phosphatase as a novel drug target against resistant strain of Mycobacterium tuberculosis (XDR1219) by using comparative metabolic pathway approach. Uddin R; Zahra NU; Azam SS Comput Biol Chem; 2019 Apr; 79():91-102. PubMed ID: 30743161 [TBL] [Abstract][Full Text] [Related]
30. Investigation of the New Inhibitors by Sulfadiazine and Modified Derivatives of α-D-glucopyranoside for White Spot Syndrome Virus Disease of Shrimp by In Silico: Quantum Calculations, Molecular Docking, ADMET and Molecular Dynamics Study. Kumer A; Chakma U; Rana MM; Chandro A; Akash S; Elseehy MM; Albogami S; El-Shehawi AM Molecules; 2022 Jun; 27(12):. PubMed ID: 35744817 [TBL] [Abstract][Full Text] [Related]
31. Elucidation of marine fungi derived anthraquinones as mycobacterial mycolic acid synthesis inhibitors: an in silico approach. Sharma A; Islam MH; Fatima N; Upadhyay TK; Khan MKA; Dwivedi UN; Sharma R Mol Biol Rep; 2019 Apr; 46(2):1715-1725. PubMed ID: 30715689 [TBL] [Abstract][Full Text] [Related]
32. Computer-aided identification of lead compounds as Staphylococcal epidermidis FtsZ inhibitors using molecular docking, virtual screening, DFT analysis, and molecular dynamic simulation. Tripathy S; Sahu SK; Azam MA; Jupudi S J Mol Model; 2019 Nov; 25(12):360. PubMed ID: 31773394 [TBL] [Abstract][Full Text] [Related]
33. Lead Molecule Prediction and Characterization for Designing MERS-CoV 3C-like Protease Inhibitors: An In silico Approach. Rahman MM; Hosen MB; Howlader MZH; Kabir Y Curr Comput Aided Drug Des; 2019; 15(1):82-88. PubMed ID: 29956635 [TBL] [Abstract][Full Text] [Related]
34. Identification of potential inhibitors for mycobacterial uridine diphosphogalactofuranose-galactopyranose mutase enzyme: A novel drug target through in silico approach. Nayak T; Jena L; Waghmare P; Harinath BC Int J Mycobacteriol; 2018; 7(1):61-68. PubMed ID: 29516888 [TBL] [Abstract][Full Text] [Related]
35. Identification of novel natural inhibitors of Opisthorchis felineus cytochrome P450 using structure-based screening and molecular dynamic simulation. Shukla R; Chetri PB; Sonkar A; Pakharukova MY; Mordvinov VA; Tripathi T J Biomol Struct Dyn; 2018 Oct; 36(13):3541-3556. PubMed ID: 29029597 [TBL] [Abstract][Full Text] [Related]
36. Structure-based virtual screening, molecular dynamics simulation and MM-PBSA toward identifying the inhibitors for two-component regulatory system protein NarL of Kumar N; Srivastava R; Prakash A; Lynn AM J Biomol Struct Dyn; 2020 Jul; 38(11):3396-3410. PubMed ID: 31422761 [TBL] [Abstract][Full Text] [Related]
37. Identification of potential inhibitors of Mycobacterium tuberculosis shikimate kinase: molecular docking, in silico toxicity and in vitro experiments. Freitas de Freitas T; Roth CD; Abbadi BL; Hopf FSM; Perelló MA; de Matos Czeczot A; de Souza EV; Borsoi AF; Machado P; Bizarro CV; Basso LA; Timmers LFSM J Comput Aided Mol Des; 2023 Mar; 37(3):117-128. PubMed ID: 36547753 [TBL] [Abstract][Full Text] [Related]
38. A probable means to an end: exploring P131 pharmacophoric scaffold to identify potential inhibitors of Cryptosporidium parvum inosine monophosphate dehydrogenase. Omolabi KF; Iwuchukwu EA; Agoni C; Olotu FA; Soliman MES J Mol Model; 2021 Jan; 27(2):35. PubMed ID: 33423140 [TBL] [Abstract][Full Text] [Related]
39. Identification of novel CDK 9 inhibitors based on virtual screening, molecular dynamics simulation, and biological evaluation. Wu M; Han J; Liu Z; Zhang Y; Huang C; Li J; Li Z Life Sci; 2020 Oct; 258():118228. PubMed ID: 32781071 [TBL] [Abstract][Full Text] [Related]
40. Structural insight into Mycobacterium tuberculosis maltosyl transferase inhibitors: pharmacophore-based virtual screening, docking, and molecular dynamics simulations. Sengupta S; Roy D; Bandyopadhyay S J Biomol Struct Dyn; 2015; 33(12):2655-66. PubMed ID: 25669125 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]